| pubmed-article:12172982 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0014582 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0030231 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:12172982 | lifeskim:mentions | umls-concept:C1519043 | lld:lifeskim |
| pubmed-article:12172982 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12172982 | pubmed:dateCreated | 2002-8-12 | lld:pubmed |
| pubmed-article:12172982 | pubmed:abstractText | Anthracyclines and taxanes are the most active cytotoxic agents in the treatment of breast cancer. Based on observations with weekly administration of paclitaxel which results in better tolerability and higher dose intensity as compared with 3-weekly schedules, we designed a phase I/II trial with weekly epidoxorubicin and docetaxel (wED) for the preoperative and palliative treatment of patients with breast cancer. | lld:pubmed |
| pubmed-article:12172982 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12172982 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12172982 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12172982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12172982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12172982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12172982 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12172982 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12172982 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:LockerGottfri... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:StegerGuenthe... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:WenzelCathari... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:JakeszRaimund... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:RudasMargaret... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:TaucherSusann... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:ZielinskiChri... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:PluschnigUrsu... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:OberhuberGerh... | lld:pubmed |
| pubmed-article:12172982 | pubmed:author | pubmed-author:GnantMichael... | lld:pubmed |
| pubmed-article:12172982 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12172982 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:12172982 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12172982 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12172982 | pubmed:pagination | 155-9 | lld:pubmed |
| pubmed-article:12172982 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:meshHeading | pubmed-meshheading:12172982... | lld:pubmed |
| pubmed-article:12172982 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12172982 | pubmed:articleTitle | Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer. | lld:pubmed |
| pubmed-article:12172982 | pubmed:affiliation | Department of Internal Medicine I/Division of Oncology, University Hospital of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. | lld:pubmed |
| pubmed-article:12172982 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12172982 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12172982 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:12172982 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12172982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12172982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12172982 | lld:pubmed |
